Evidence map›Paper›PMID 27421052›Full record

ArticleAIDS care2016

"How can I tell?" Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV "test-and-treat" trial.

Irene Maeri, Alison El Ayadi, Monica Getahun, Edwin Charlebois, Cecilia Akatukwasa, Dennis Tumwebaze, Harriet Itiakorit, Lawrence Owino, Dalsone Kwarisiima, Emmanuel Ssemmondo and 10 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in AIDS care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01864603 nacompletednot on this map

Sustainable East Africa Research in Community Health

TypeinterventionalSponsorUniversity of California, San FranciscoRan2013 to 2021Enrolled150,395ConditionsHIV, Tuberculosis, Hypertension, DiabetesArmsUniversal ART in a streamlined care model, Annual Community Health Campaigns, Targeted PrEP and Targeted testing interventions, Baseline community-based HIV and multi-disease testing
NCT04115813 nacompletednot on this mapstarted 2017, after this paper: background citation

Transitioning Adolescents to HIV Self-Management in Zambia (Known as: Project YES: Youth Engaging for Success)

TypeinterventionalSponsorJohns Hopkins Bloomberg School of Public HealthRan2017 to 2019Enrolled276ConditionsHIV/AIDSArmsProject YES! Youth Engaging for Success
3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. "AIDS care · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Irene Maeria Centre for Microbiology Research , Kenya Medical Research Institute , Nairobi , Kenya.
Alison El Ayadib Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology & Reproductive Sciences , University of California , San Francisco , CA , USA.
Monica Getahunb Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology & Reproductive Sciences , University of California , San Francisco , CA , USA.
Edwin Charleboisc Center for AIDS Prevention Studies , University of California , San Francisco , CA , USA.
Cecilia Akatukwasad Infectious Diseases Research Collaboration , Kampala , Uganda.
Dennis Tumwebazed Infectious Diseases Research Collaboration , Kampala , Uganda.
Harriet Itiakoritd Infectious Diseases Research Collaboration , Kampala , Uganda.
Lawrence Owinoa Centre for Microbiology Research , Kenya Medical Research Institute , Nairobi , Kenya.
Dalsone Kwarisiimae Makerere University Joint AIDS Program , Kampala , Uganda.
Emmanuel Ssemmondod Infectious Diseases Research Collaboration , Kampala , Uganda.
Norton Sanga Centre for Microbiology Research , Kenya Medical Research Institute , Nairobi , Kenya.
Jane Kabamid Infectious Diseases Research Collaboration , Kampala , Uganda.
Tamara D Clarkf Department of HIV, Infectious Disease and Global Medicine , University of California , San Francisco , CA , USA.
Maya Peterseng Divisions of Biostatistics and Epidemiology, School of Public Health , University of California , Berkeley , CA , USA.
Craig R Cohenb Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology & Reproductive Sciences , University of California , San Francisco , CA , USA.
Elizabeth A Bukusia Centre for Microbiology Research , Kenya Medical Research Institute , Nairobi , Kenya.
Moses Kamyad Infectious Diseases Research Collaboration , Kampala , Uganda.
Diane Havlirf Department of HIV, Infectious Disease and Global Medicine , University of California , San Francisco , CA , USA.
Carol S Camlinb Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology & Reproductive Sciences , University of California , San Francisco , CA , USA.
SEARCH Collaboration
Infectious Diseases Research Collaboration · UGKenya Medical Research Institute · KEUniversity of California, San Francisco · USIbis Reproductive Health · USMakerere University · UGUniversity of California, Berkeley · US

Funding

Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)U01AI099959 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2012 to 2016
$39.7M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
NIAID NIH HHS U01 AI099959NIAID NIH HHS UM1 AI069496PEPFAR
6 · The paper itself

Abstract

People living with HIV/AIDS anticipate HIV-related stigma and fear disclosure to intimate partners. Yet, disclosure is critical to reducing HIV transmission and improving care engagement. This qualitative study characterized HIV disclosure experiences and normative beliefs among couples in communities participating in an HIV test-and-treat trial in Kenya and Uganda (Sustainable East Africa Research in Community Health, NCT#01864603). In-depth interviews were conducted with care providers (n = 50), leaders (n = 32) and members (n = 112) of eight communities. Data were analyzed using grounded theoretical approaches and Atlas.ti software. Findings confirmed gender differences in barriers to disclosure: while both men and women feared blame and accusation, women also feared violence and abandonment ("I did not tell my husband because [what if] I tell him and he abandons me at the last moment when I am in labor?"). Positive consequences included partner support for increased care-seeking and adherence ("My husband keeps on reminding me 'have you taken those drugs?'") Yet negative consequences included partnership dissolution, blame, and reports of violence ("some men beat their wives just because of that [bringing HIV medications home]"). Among HIV-infected individuals in discordant relationships, men more often reported supportive spouses ("we normally share [HIV-risk-reduction strategies] since I have been infected and she is HIV negative"), than did women ("my husband refused to use condoms and even threatened to marry another wife"). Care providers lent support for HIV-positive women who wanted to engage partners in testing but feared negative consequences: "They engaged the two of us in a session and asked him if we could all test." Findings demonstrate differing experiences and support needs of women and men living with HIV in eastern Africa, with HIV-positive women in discordant couples particularly vulnerable to negative consequences of disclosure. Efforts to strengthen capacity in health systems for gender-sensitive clinician- or counselor-assisted disclosure should be accelerated within test-and-treat efforts.

Indexed as

Social StigmaTruth DisclosureBlack PeopleCondomsFemaleHIV InfectionsHumansInterpersonal RelationsInterviews as TopicKenyaMaleQualitative ResearchSexual PartnersSpousesUgandaViolenceHIV-related stigmaHIV sero-discordant couplessub-Saharan Africa

Identifiers

PMID27421052
PMCPMC5751752
OpenAlexW2474982830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.